0NQH Stock Financial Analysis - RHÖN-KLINIKUM Aktiengesellschaft (LSE) Stock

RHÖN-KLINIKUM Aktiengesellschaft
GB ˙ LSE ˙ DE0007042301
€11.75 0.00 (0.00%)
2025-09-05
SHARE PRICE
Overview
RHÖN-KLINIKUM Aktiengesellschaft, based in Germany, is a major healthcare provider primarily engaged in the operation of hospitals and medical centers. As a leading entity within the healthcare industry, the company focuses on delivering high-standard medical services across acute care, maximum care, and telemedicine. Noteworthy projects highlight its commitment to advancing medical capabilities and include the implementation of innovative health technology solutions aimed at improving patient outcomes and operational efficiency. RHÖN-KLINIKUM prioritizes the integration of research and clinical practice, leveraging its network of facilities to set benchmarks in patient care, which significantly contributes to the healthcare sector in Germany and enhances its portfolio in specialized medical services.
Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income
  • The revenue for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 1,917.80 MM.
  • The operating income for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 46.27 MM.
  • The net income for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 37.68 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2025-06-30 1,917.80 46.27 37.68
2025-03-31 1,891.99 45.19 39.69
2024-12-31 1,867.86 47.15 43.35
2024-09-30 1,835.33 49.19 44.87
2024-06-30 1,802.39 45.33 46.53
2024-03-31 1,767.35 42.76 43.25
2023-12-31 1,734.72 39.00 38.71
2023-09-30 1,713.79 30.01 31.92
2023-06-30 1,693.97 28.34 25.62
2023-03-31 1,690.24 38.70 30.40
2022-12-31 1,661.16 31.31 25.14
2022-09-30 1,640.02 30.66 29.97
2022-06-30 1,627.96 31.21 31.75
2022-03-31 1,601.70 24.71 28.18
2021-12-31 1,591.21 27.72 28.30
2021-09-30 1,557.21 14.96 14.63
2021-06-30 1,553.74 16.91 13.74
2021-03-31 1,548.84 5.46 7.01
2020-12-31 1,546.06 7.33 1.45
2020-09-30 1,536.92 12.97 7.92
2020-06-30
2020-03-31
Income Statement: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31
2024-09-30 0.67 0.67
2024-06-30 0.70 0.70
2024-03-31 0.65 0.65
2023-12-31 0.58 0.58
2023-09-30 0.49 0.49
2023-06-30 0.38 0.39
2023-03-31 0.45 0.46
2022-12-31 0.38 0.38
2022-09-30 0.44 0.44
2022-06-30 0.47 0.47
2022-03-31 0.40 0.40
2021-12-31 0.42 0.42
2021-09-30 0.24 0.24
2021-06-30 0.21 0.20
2021-03-31 0.11 0.10
2020-12-31 0.02 0.02
2020-09-30 0.11 0.11
2020-06-30 0.29 0.29
2020-03-31 0.46 0.46
Cash Flow: Operations, Investing, Financing
  • The cash from operating activities for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 61.70 MM.
  • The cash from investing activities for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is -115.60 MM.
  • The cash from financing activities for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is -10.80 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2025-06-30 61.70 -115.60 -10.80
2025-03-31
2024-12-31 127.60 -50.40 -3.30
2024-09-30
2024-06-30 142.30 43.90 -11.20
2024-03-31
2023-12-31 109.00 40.90 -21.20
2023-09-30
2023-06-30 43.30 -52.40 -14.00
2023-03-31
2022-12-31 60.30 -105.20 -4.10
2022-09-30
2022-06-30 48.40 -126.10 -3.90
2022-03-31
2021-12-31 97.50 -58.30 -3.90
2021-09-30
2021-06-30 116.70 -43.40 -15.20
2021-03-31
2020-12-31 113.30 -135.20 -15.10
2020-09-30 113.10 -96.80 -16.00
2020-06-30
2020-03-31
Valuation Metrics : PE, PriceToBook, PriceToTBV
  • The p/e for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 19.69.
  • The p/book for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.59.
  • The p/tbv for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.69.
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2025-06-30 19.69 0.59 0.69
2025-03-31 20.30 0.66 0.76
2024-12-31 20.66 0.71 0.95
2024-09-30 17.91 0.64 0.74
2024-06-30 18.26 0.61 0.73
2024-03-31 20.23 0.61 0.73
2023-12-31 23.69 0.60 0.71
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30 58.46 0.67 0.79
2021-03-31 114.52 0.67 0.95
2020-12-31 553.59 0.67 0.80
2020-09-30 101.41 0.67 0.79
2020-06-30 41.82 0.68 0.80
2020-03-31 26.34 0.68 0.80
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
  • The ebit/ev for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.08.
  • The ebit (3y)/ev for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.07.
Period End (TTM) EBIT/EV EBIT (3y)/EV
2025-06-30 0.08 0.07
2025-03-31 0.07 0.06
2024-12-31 0.07 0.06
2024-09-30 0.08 0.06
2024-06-30 0.07 0.05
2024-03-31 0.06 0.05
2023-12-31 0.05 0.04
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30 0.02 0.05
2021-03-31 0.01 0.04
2020-12-31 0.00 0.05
2020-09-30 0.02 0.05
2020-06-30 0.03 0.04
2020-03-31 0.05 0.05
Management Effectiveness
  • The roa for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.02.
  • The roe for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.03.
  • The roic for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.03.
  • The croic for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.05.
  • The ocroic for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.09.
Period End (TTM) ROA ROE ROIC CROIC OCROIC
2025-06-30 0.02 0.03 0.03 0.05 0.09
2025-03-31 0.02 0.03 0.03 0.00 0.00
2024-12-31 0.03 0.03 0.03 0.12 0.10
2024-09-30 0.03 0.04 0.03 0.12 0.10
2024-06-30 0.02 0.03 0.03 0.09 0.08
2024-03-31 0.02 0.03 0.03 0.09 0.08
2023-12-31 0.02 0.03 0.02 -0.02 0.01
2023-09-30 0.02 0.02 0.02 -0.02 0.01
2023-06-30 0.02 0.02 0.02 -0.02 0.01
2023-03-31 0.02 0.02 0.02 -0.03 0.03
2022-12-31 0.02 0.02 0.02 0.00 0.00
2022-09-30 0.02 0.02 0.02 -0.06 0.03
2022-06-30 0.02 0.03 0.02 -0.06 0.03
2022-03-31 0.02 0.02 0.02 0.03 0.07
2021-12-31 0.01 0.02 0.02 0.03 0.00
2021-09-30 0.01 0.01 0.01 0.04 0.09
2021-06-30 0.01 0.01 0.01 0.04 0.09
2021-03-31 0.00 0.01 0.01 -0.03 0.08
2020-12-31 0.00 0.00 0.00 -0.03 0.08
2020-09-30 0.00 0.01 0.01 0.00 0.08
2020-06-30 0.01 0.02 0.01 0.02 0.07
2020-03-31 0.02 0.03 0.02 0.04 0.05
Gross Margins
  • The gross margin for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.11.
  • The net margin for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.02.
  • The operating margin for RHÖN-KLINIKUM Aktiengesellschaft as of 30 June 2025 is 0.02.
Gross Margin
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Net Margin
The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
Operating Margin
The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) Gross Margin Net Margin Operating Margin
2025-06-30 0.11 0.02 0.02
2025-03-31 0.15 0.02 0.03
2024-12-31 0.12 0.02 0.03
2024-09-30 0.12 0.03 0.03
2024-06-30 0.12 0.02 0.02
2024-03-31 0.12 0.02 0.02
2023-12-31 0.12 0.02 0.02
2023-09-30 0.11 0.02 0.02
2023-06-30 0.12 0.02 0.02
2023-03-31 0.16 0.02 0.02
2022-12-31 0.12 0.02 0.02
2022-09-30 0.12 0.02 0.02
2022-06-30 0.12 0.02 0.02
2022-03-31 0.11 0.02 0.02
2021-12-31 0.10 0.02 0.02
2021-09-30 0.11 0.01 0.02
2021-06-30 0.11 0.01 0.02
2021-03-31 0.11 0.00 0.01
2020-12-31 0.10 0.00 0.01
2020-09-30 0.11 0.01 0.01
2020-06-30 0.11 0.01 0.01
2020-03-31 0.10 0.02 0.00
Identifiers and Descriptors
Central Index Key (CIK)
Industry Groups
Other Listings
GB:RHKd
DE:RHK €11.70
CH:RHK
US:RHKJF
AT:RHK
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.

About Fintel
Top Investors
Features
Explore
Help Center